High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
Crossref DOI link: https://doi.org/10.1007/s10549-017-4160-5
Published Online: 2017-02-17
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yndestad, Synnøve
Austreid, Eilin
Knappskog, Stian
Chrisanthar, Ranjan
Lilleng, Peer Kåre
Lønning, Per Eystein
Eikesdal, Hans Petter
Funding for this research was provided by:
Helse Vest
Bergens Forskningsstiftelse
Kreftforeningen
Rieber Foundation
License valid from 2017-02-17